Results 231 to 240 of about 25,658,089 (295)

Development of a Genetically Characterized Panel of 15 Mucosal Melanoma Cell Lines for the Preclinical Evaluation of Targeted Therapies in Human and Veterinary Medicine

open access: yesPigment Cell &Melanoma Research, Volume 39, Issue 6, November 2026.
Development and genetic characterisation of canine mucosal melanoma cell lines for in vitro and in vivo drug screening. ABSTRACT Mucosal melanoma (MM) is a rare and aggressive cancer in humans, with limited therapeutical options and no faithful models for preclinical research.
Caroline Confais   +11 more
wiley   +1 more source

Endothelial Matrin‐3 Limits Cellular Senescence and Lipid Dysregulation to Protect Against Murine Atherosclerosis

open access: yesThe FASEB Journal, Volume 40, Issue 20, 31 October 2026.
Endothelial Matrin‐3 suppresses cellular senescence and protects against atherosclerosis. Matrin‐3 deficiency induces endothelial senescence, mitochondrial dysfunction, and activation of p53‐, cell cycle‐, and senescence‐related pathways. In atherosclerosis‐prone mice, endothelial Matrin‐3 deletion promotes atherosclerotic lesion formation and disrupts
Xiao Cheng   +5 more
wiley   +1 more source

HIF inhibition: Current strategies and clinical challenges. [PDF]

open access: yesRedox Biol
Więch-Walów A   +7 more
europepmc   +1 more source

Diethylene Glycol‐Linked Ring‐Fused Bis‐Azoles: Target‐Oriented Synthesis, In Silico Screening, and Antitumor Activity

open access: yesChemMedChem, Volume 21, Issue 19, 14 October 2026.
A series of diethylene glycol‐linked cyclic derivatives with diversity in the heterocyclic motif have been synthesized and screened for antitumor activity. Two bis‐thiazolo[3,2‐a]pyrimidinone derivatives displayed moderate cytotoxicity, high selectivity against hepatocellular carcinoma cells, promising VEGFR2, and remarkable FGFR2 inhibitory activities
Sami A. Al‐Hussain   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy